20517 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
Sub-classes:ASCAROSIDE DERIVATIVES
#2MODULATORS OF RAR RELATED ORPHAN RECEPTORS (RORs)
#3COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER
#4COMPOSITION AND FOOD SUPPLEMENTARY FOR SARCOPENIA AND PERIODONTAL DISEASES CONTAINING ALDER AND ELM COMPLEX EXTRACTS AS ACTIVE INGREDIENTS
#5CANCER IMMUNOTHERAPY
#6Hydrolyzed Pea Protein-Based Nutrient Composition
#7SULFORAPHANE SUPPLEMENT IN GUMMY FORM
#8COMPOSITIONS AND METHODS FOR THE PREVENTION OF LOSS OF ORGAN FUNCTION ASSOCIATED WITH CHRONIC ORGAN DISEASE
#9Anti-Cancer Saccharide-Linked Dithiocarbamate Compounds
#10METHODS AND MATERIALS FOR TREATING OBESITY
#11ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS
#12COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#13BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#14ISOPROPYL-D-GLUCOPYRANOSIDE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#15A TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#16METHOD FOR THE SYNTHESIS OF EVOC PROBES
#17FORMULATIONS COMPRISING TRIPTAN COMPOUNDS
#18PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
#19UTILITY OF NEMATODE SMALL MOLECULES
#20MOLECULAR COMPLEXING METHOD, FORMULATION AND MANUFACTURING FOR ENHANCED NUTRIENT DELIVERY
#21COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING DRY EYE SYNDROME OR MEIBOMIAN GLAND DYSFUNCTION
#22CONSTRUCTION AND APPLICATION OF ENHANCED NEUTROPHIL DRUG
#23LONG-CHAIN COMPOUND AND USE THEREOF
#24COMPOSITION FOR IMPROVING IMMUNITY OF COMPANION ANIMALS
#25BIOACTIVES AND THEIR USES
#26COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE
#27METHODS OF TREATING MIGRAINE
#28ALTERING CANCER CELLULAR FUNCTIONS THROUGH PROTON MOPPING
#29SYNTHETIC COMPOUND, KIT COMPRISING THE SAME, AND USES THEREOF
#30BACTERIAL CAPSULAR OLIGOSACCHARIDE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#31A-SALIDROSIDE, METHOD FOR PREPARING SAME, AND APPLICATION THEREOF
#32LACTOBACILLUS PLANTARUM ZUST49 AND BACTERIAL AGENT, AND USE THEREOF
#33Bifidobacterium longum CCFM1206 capable of producing sulforaphane and relieving inflammation
#34Hepatitis B Antiviral Agents
#35COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER
#36THERAPEUTIC COMPOSITIONS AND RELATED METHODS
#37Pharmaceutical Composition for Improving and Treating Leukotrichia and/or Alopecia and Preparation Method Thereof
#38Treatment of hearing loss
#39TREATMENT OF KNOWN AND UNKNOWN VIRAL INFECTION WITH LIPID AGENTS
#40METHODS OF TREATING OR PREVENTING ALLERGIES AND CHRONIC NASAL CONGESTION
#41MODIFIED OLIGOMERIC COMPOUNDS COMPRISING TRICYCLO-DNA NUCLEOSIDES AND USES THEREOF
#42Topical Compositions Comprising (Glyco)Sphingolipids and/or (Glyco)Ceramides
#43TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#44ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE
#45COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS
#46METHOD FOR TREATING CANCER
#47TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#48Biosurfactant Formulations for Use in Skincare and Wound Treatment
#49TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION
#50METHODS FOR IMPROVING PHYSICAL EXERCISE PERFORMANCE
#51Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion
#52ANTI-INFLAMMATORY PHYTONUTRIENTS FOR USE IN THE TREATMENT OR PREVENTION OF SYNOVITIS
#53PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
#54ANTIVIRAL SUPPLEMENT FORMULATIONS
#55COMPOSITION FOR INHIBITING PARKINSON'S DISEASE AND METHOD OF MANUFACTURING THE SAME
#56Utility of nematode small molecules
#57USE OF CRASSOCEPHALUM RABENS EXTRACT IN THE PREVENTION AND/OR TREATMENT OF FATIGUE AND/OR DEPRESSION
#58HEXOSAMINE COMPOUNDS AND METHODS THEREOF
#59NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
#60ETHANOLIC EXTRACT OF SEEDS OF SOLANUM MELONGENA, METHOD FOR OBTAINING IT, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE THEREOF AS AN ANTITUMOUR AGENT
#61Therapeutic Agent for Progressive Disease Caused by Increase in Eomes-Positive CD4-Positive T Cells
#62COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#63COMPOSITIONS AND METHODS FOR ANXIETY DISORDER TREATMENT
#64USE OF SGLT-2 INHIBITORS IN THE DRYING-OFF OF NON-HUMAN MAMMALS
#65CORONAVIRUS TREATMENT COMPOSITION AND METHOD
#66TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING INDIVIDUALS
#67USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES
#68Treatment of hearing loss
#69INFANT FORMULA MILK POWDER RICH IN MILK FAT GLOBULE MEMBRANE PROTEIN, PHOSPHOLIPIDS AND OLIGOSACCHARIDES AND PREPARATION METHOD THEREFOR
#70Compounds for treating and preventing extracellular histone mediated pathologies
#71Hepatitis B antiviral agents
#72BREVUNDIMONAS SP FOR USE IN DISEASE PREVENTION AND TREATMENT
#73COMPOSITIONS COMPRISING AND METHODS OF USING INHIBITORS OF SODIUM-GLUCOSE COTRANSPORTERS 1 AND 2
#74Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
#75COMPOSITIONS AND METHODS FOR JOINT HEALTH
#76CLEARANCE OF SENESCENT CELLS BY ACTIVATION OF iNKT CELLS
#77Methods and composition for induction of immune response
#78METHODS AND COMPOSITIONS RELATING TO IMPROVED COMBINATION THERAPIES
#79USE OF SOPHOROLIPIDS AS FEED ADDITIVE
#80COMPOSITIONS AND METHODS FOR NANOPARTICLE-BASED DRUG DELIVERY AND IMAGING
#81SYNTHETIC AGONISTS OF TLR4 RECEPTOR
#82STERICALLY STABILIZED CARRIER FOR AEROSOL THERAPEUTICS, COMPOSITIONS AND METHODS FOR TREATING THE RESPIRATORY TRACT OF A MAMMAL
#83ASCAROSIDE TREATMENT OF EOSINOPHILIC ESOPHAGITIS
#84Formulations comprising triptan compounds
#85Utility of nematode small molecules
#86COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA
#87INOSITOL PHOSPHATE-CONTAINING COMPOSITION
#88UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#89UV BLOCKING COMPOSITION COMPRISING RED ALGAE-DERIVED FLORIDOSIDE AND AMINE GROUP-CONTAINING COMPOUND
#90METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS
#91Antiviral supplement formulations
#92USE OF E-SELECTIN ANTAGONISTS TO ENHANCE THE SURVIVAL OF RECONSTITUTED, BONE MARROW-DEPLETED HOSTS
#93USE OF SOTAGLIFLOZIN FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND MODERATE RENAL IMPAIRMENT
#94Composition and Concentrate for Use in Preparation of Dialysis Solution, Corresponding Dialysis Solution and Combinations Comprising Container
#95Compounds for treating and preventing net associated complications
#96FEED FOR ENHANCING IMMUNITY OF TILAPIA AND PREPARATION METHOD THEREOF
#97Mannose derivatives for treating bacterial infections
#98COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER
#99PHARMACEUTICAL PREPARATION OF CARBOHYDRATES FOR THERAPEUTIC USE
#100METHODS OF TREATING MIGRAINE
#101Method for treating dupuytren's disease
#102COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#103LOW CONTAMINANT COMPOSITIONS
#104ASCAROSIDE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES
#105Enhanced in Vivo Targeting of Site-Specific Drugs
#106Agents for use in the treatment of cardiac arrhythmia
#107Hydrolyzed Pea Protein-Based Nutrient Composition
#108COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF CONDITIONS RELATED TO THE QUALITY OF AGING AND LONGEVITY
#109USE OF MANNOSE 6 PHOSPHATE AND MODIFICATIONS THEREOF FOR MEMORY ENHANCEMENT AND REDUCING MEMORY IMPAIRMENT
#110NOVEL TLR4 INHIBITORS FOR THE TREATMENT OF HUMAN INFECTIOUS AND INFLAMMATORY DISORDERS
#111ALTERING CANCER CELLULAR FUNCTIONS THROUGH PROTON MOPPING
#112Low contaminant compositions
#113Hepatitis B antiviral agents
#114GLUCOCEREBROSIDE TREATMENT OF DISEASE
#115METHODS OF INHIBITION OF PROTEIN FUCOSYLATION IN VIVO USING FUCOSE ANALOGS
#116Method of ingesting supplements in connection with an airplane flight
#117Compounds for treating and preventing extracellular histone mediated pathologies
#118Panax plant extract and pharmaceutical composition and use thereof
#119Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
#120Inositol phosphate-containing composition
#121Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
#122OPHTHALMIC DRUG PREPARATION AND USES THEREOF
#123Use of SGLT-2 inhibitors in the drying-off of non-human mammals
#124ANTIFIBROTIC COMPOSITION
#125Compositions and methods for treatment of inflammatory disorders
#126Compositions and Methods for Treating Inflammatory Bowel Diseases (IBDs) and Other Disorders
#127PROTECTING A BIOACTIVE AND/OR PRECURSOR THEREOF
#128Method for preventing or treating hangover symptom(s) associated with consumption of alcoholic beverage(s)
#129COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ATYPICAL BRAF MUTATIONS
#130Combination of Rhodiola and Astragalus for the treatment of neurodegenerative diseases
#131HONEY-BASED GEL COMPOSITION
#132FORMULATION OF GLUCOSINOLATES AND MYROSINASE
#133Hydrolyzed pea protein-based nutrient composition
#134Treatment of hearing loss
#135Synthetic disugar hydrocarbons as natural analogs to control microbial behaviors
#136COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM
#137COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC LIVER DISEASE OR INSULIN RESISTANCE COMPRISING GINSENOSIDE F2
#138Regulation of cancer using natural compounds and/or diet
#139MEDICINAL COMPOSITION FOR TREATING URINARY TRACT INFECTION (UTI)
#140compositions and methods thereof
#141Modified oligomeric compounds comprising tricyclo-DNA nucleosides and uses thereof
#142Pharmaceutical use of argininyl fructosy glucose
#143Use of sophorolipids as feed additive
#144Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#145Composition and methods of treating acne and photoaging
#146Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
#147Extended release immunomodulatory implant to facilitate bone morphogenesis
#148METHOD AND DEVICE FOR ANNIHILATION OF Staphylococcus aureus
#149Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
#150Method for treating skin irritation caused by parabens
#151Formulations comprising triptan compounds
#152GLUCOCEREBROSIDE TREATMENT OF DISEASE
#153ANTIBACTERIAL COMPOSITION CONTAINING A DEOXYHEXOSE ALKYL MONOACETAL OR MONOETHER
#1542,7-dibromospiro[fluorene-9,4′-piperidine] compounds
#155Lipid supplements for reducing nerve action potentials
#156UTILITY OF NEMATODE SMALL MOLECULES
#157Compositions comprising sulforaphane or a sulforaphane precursor and a milk thistle extract or powder
#158PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PROSTATIC HYPERPLASIA
#159Drug composition for parenteral administration
#160Compositions And Methods For Immunotherapy
#161Pharmaceutical preparation of carbohydrates for therapeutic use
#162ACTIVATION OF iNKT CELLS
#163NUTRITIONAL FORMULATIONS USING HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION
#164HONEY-BASED GEL COMPOSITION
#165BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#166Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
#167GLYCOLIPIDS AS TREATMENT FOR DISEASE
#168Therapeutical methods, formulations and nutraceutical formulations
#169compositions and methods thereof
#170BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#171Enhanced in vivo targeting of radiolabelled peptides with the means of enzyme inhibitors
#172Functionalized saccharides as anti-inflammatory agents
#173Lipid A mimics, methods of preparation, and uses thereof
#174Antiviral supplement formulations
#175Thiosaccharide mucolytic agents
#176Compositions comprising sulforaphane or a sulforaphane precursor and a mushroom extract or powder
#177NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF
#178Methods of inhibition of protein fucosylation in vivo using fucose analogs
#179THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS
#180USE OF PHENOTHIAZINE DERIVATIVE IN THE TREATMENT OF INFECTIOUS PURPURA OR PURPURA FULMINANS
#181USE OF 6-O-(C8-C20 ALKYL ESTER) OF 1-O-(C1-C6 ALKYL)-ß-D-GLUCOSIDE AS AN AGENT FOR PROTECTING THE SKIN
#182Aronia extract for enhancing reaction time and attention
#183Synthetic vaccines against serotype 2
#184Compositions And Methods For Immunotherapy
#185Prosthetic tissue valves
#186TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#187Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating induced inflammatory bowel diseases such as crohn's disease
#188Hydrolyzed pea protein-based nutrient composition
#189METHODS OF TREATMENT
#190Prodrugs of Chlorokynurenines
#191CARRIER COMPOSITION
#192SYNTHETIC DISUGAR HYDROCARBONS AS NATURAL ANALOGS TO CONTROL MICROBIAL BEHAVIORS
#193Compounds for treatment of lipoprotein metabolism disorders
#194GLA monotherapy for use in cancer treatment
#195Sphingamide compounds and methods for binding iNKT cells
#196COMBINATIONS OF BETA-GLYCOLIPIDES AND 4-[(2-AMINO-3,5-DIBROMOPHENYL)METHYLAMINO]CYCLOHEXAN-1-OL, COMPOSITIONS AND USES THEREOF IN THE TREATMENT OF DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING AND PROTEIN AGGREGATIONS
#197Agent for treating retinopathy
#198compositions and methods thereof
#199Treatment of Fabry disease
#200NOOTROPIC AND SKIN SUPPLEMENT COMPOSITIONS AND METHOD TO PROVIDE A TAILORED SUPPLEMENT
#201Microbial carotenoids affecting gut microbial composition
#202Ascaroside treatment of eosinophilic esophagitis
#203Ascaroside treatment of autoimmune and inflammatory diseases
#204Compositions comprising sulfated polysaccharides and uses thereof
#205Crystal forms of sodium-glucose co-transporter inhibitor, processes for preparation and use thereof
#206BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE
#207Utility of nematode small molecules
#208NOVEL ACTIVE INGREDIENT IN CICATRIZATION AND USE THEREOF
#209Desensitizing mast cells by co-presentation of antigens with high affinity mast cell siglec ligands
#210Compositions and methods for treating infectious disease
#211Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#212Pharmaceutical Peptides and Rhamnolipid Liposomes
#213Mannose derivatives for treating bacterial infections
#214SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE
#215S- Methylcysteine Sulfoxide For Prostate Cancer Prevention And Treatment
#216Glucocerebroside treatment of disease
#217Oral lipid supplements for treating pain and fibromyalgia
#218Hepatitis B antiviral agents
#219Fatty-acid based particles
#220Bacterial ghosts for the treatment of cancer
#221Beneficial effect of on fat decrease and muscle increase
#222NANOPARTICLE-AQUEOUS DISPERSION LIQUID OF GLYCOSPHINGOLIPID
#223GLYCOLIPID COMPOUNDS AND THEIR USES IN THE TREATMENT OF TUMOURS
#224Composition for treating neuropathy, process and method of treatment thereof
#225Thiocarbamate prodrugs of tofacitinib
#226BONE TARGETED THERAPEUTICS AND METHODS OF MAKING AND USING THE SAME
#227BENEFICIAL EFFECTS OF BIDENS PILOSA ON GUT MICROFLORA AND ANIMAL HEALTH
#228PRODRUGS OF CHLOROKYNURENINES
#229Methods of inhibiting the virulence of a pathogen with an oxidized tannin to treat a gastrointestinal spasm
#230Compositions and methods of treating acne and photoaging
#231ALTERING CANCER CELLULAR FUNCTIONS THROUGH PROTON MOPPING
#232Vaccines against serotype 5
#233COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING HYALURONIC ACID AND EGGSHELL MEMBRANE COMPONENTS
#234Compositions and methods for treatment of inflammatory disorders
#235COMPOSITIONS AND METHODS THAT INHIBIT QUORUM SENSING
#236Antiviral supplement formulations
#237Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#238COMPOSITIONS AND METHODS FOR RESTORING THE IMMUNE SYSTEM
#239INHIBITION OF CXCR4 SIGNALING IN CANCER IMMUNOTHERAPY
#240SULFOLIPIDS AS NEW GLUTAMINYL CYCLASE INHIBITORS
#241Compositions and methods for borocarbohydrate complexes
#242compositions and methods thereof
#243FORMULATION OF GLUCOSINOLATES AND MYROSINASE
#244Formulations comprising triptan compounds
#245COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MUSHROOM EXTRACT OR POWDER
#246Glucoraphnin for use in the treatment and/or prevention of diabetes mellitus
#247Utility of nematode small molecules
#248COMPOUNDS, COMPOSITIONS, AND METHODS FOR INCREASING CFTR ACTIVITY
#249Methods of treating a treatment-resistant gastrointestinal spasm with an oxidized tannin
#250Thiosaccharide mucolytic agents
#251USE OF SAFFRON AND/OR SAFRANAL AND/OR CROCIN AND/OR PICROCROCIN AND/OR DERIVATIVES THEREOF AS A SATIATION AGENT FOR THE TREATMENT OF OBESITY
#252THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS
#253Vaccine formulation, preparation method therefor and use thereof
#254Vaccines against carbapenem-resistant
#255Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#256Phillygenin glucuronic acid derivative as well as preparation method and application thereof
#257COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN
#258METHOD FOR TREATING HIV
#259Multi-Step Connective Tissue Stabilization Method and Stabilized Tissue Formed Thereby
#260Pharmaceutical preparation of carbohydrates for therapeutic use
#261Lipid A mimics, methods of preparation, and uses thereof
#262Methods and compositions for induction of immune response
#263Methods of treatment using purified (decolorized) aloe vera leaf dry juice
#264Methods of treating a treatment-resistant gastrointestinal spasm
#265Medicinal composition for treating urinary tract infection (UTI)
#266Antibacterial composition comprising an acetal or a long-chain alkyl hexitane ether
#267Composition to Reduce DNA and Hepatic Damage and to Enhance Repair Thereof
#268Antibacterial composition containing an isomer mixture of monosaccharide alkyl monoacetals or monoethers
#269CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF
#270Chewable lipid supplements for treating pain and fibromyalgia
#271Self assembled gels for controlled delivery of encapsulated agents to cartilage
#272Aqueous solution formulations of vancomycin
#273Compositions and methods for improved muscle metabolism
#274THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID COMPOSITION AND ASSOCIATED METHOD
#275Methods Of Treatment
#276Compositions based on saffron for the prevention and/or treatment of corneal dystrophies
#277Functionalizing nanofibres
#278ANTI-BLEPHARITIS COMPOSITIONS AND THEIR USE
#279Vaccines against serotype 8
#280and polyacetylenic compounds for prevention and treatment of coccidiosis
#281Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels and rhamnose-linked gaels as cytotoxic agents against epithelial cancer cells and cancer stem cells
#282Anti-Cancer Therapies
#283BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#284Compositions based on saffron for the prevention and/or treatment of degenerative eye disorders
#285TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
#286SODIUM GLUCOSE CO-TRANSPORTER INHIBITORS AND METHODS OF THEIR USE
#287MOENOMYCIN BIOSYNTHESIS-RELATED COMPOSITIONS AND METHODS OF USE THEREOF
#288IMMUNOGENIC LIPOSOMAL FORMULATION
#289CLEANSING AGENTS CONTAINING BIOSURFACTANTS AND HAVING PREBIOTIC ACTIVITY
#290Composition and methods of treating acne and photoaging
#291Pdia4 protein as a target for diagnosis, monitoring and treatment of diabetes
#292Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A, Ginkgo biloba, and vitamin B complex
#293Compositions and methods for enhancing brain function using acetyl-L-carnitine, huperzine A and ginkgo biloba
#294SYNAPTOJANIN-2 INHIBITORS FOR USE IN THE TREATMENT OF CANCER
#295METHOD FOR TREATING ITCHING
#296COMBINATION OF BETA-GLUCOSYLCERAMIDE AND POLYETHOXYLATED CASTOR OIL AND OTHER ADJUVANTS FOR CONTROLING BLOOD SUGAR LEVELS, IMMUNOPROTECTION AND HEPATOPROTECTION
#297MODULARION OF INVARIANT NATURAL KILLER T CELLS IN THE TREATMENT OF SEPSIS
#298Methods and compositions for treatment of drug addiction
#299Chewable lipid supplements containing caffeine for increasing alertness, focus and energy
#300Compositions and methods for combination ingredient delivery